TF-positive MVs, which are associated with an increased risk of thrombosis in cancer patients due to their procoagulant properties [47], were found at significantly higher levels in CRC patients in our study as well as others [38,48,49,50]. This evidence concerns the gene TF and colorectal carcinoma.